Age De-escalation Safety Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Clinical trial NCT06652737 · COMPLETED

Trial details

NCT number: NCT06652737
Sponsor: Sanaria Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malaria Falciparum Malaria Infection

Start date: 2025-03-04
Primary completion: 2026-02-18
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.